Responsiveness of patient-based and external rating scales in multiple sclerosis: Head-to-head comparison in three clinical settings

Journal of the Neurological Sciences

Volumn 290, Issue 1-2, 2010, Pages 102-106

  Gold, Stefan M ^b   Schulz, Holger ^a   Stein, Heike ^a   Solf, Katrin ^a   Schulz, Karl Heinz ^a   Heesen, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Minimally important difference; Multiple sclerosis; Quality of life; Rehabilitation; Responsiveness

Indexed keywords

ADULT; AEROBIC EXERCISE; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HEALTH STATUS; HUMAN; INTERVENTION STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REHABILITATION CARE; TRAINING;

ADULT; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICAL FITNESS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 74849105472     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.10.020     Document Type: Article

References (27)

1. Sharrack B., Hughes R.A., Soudain S., and Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 122 Pt 1 (Jan 1999) 141-159
2. Cutter G.R., Baier M.L., Rudick R.A., Cookfair D.L., Fischer J.S., Petkau J., et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122(Pt 5) 3 (1999) 871-882
3. Kragt J.J., Thompson A.J., Montalban X., Tintore M., Rio J., Polman C.H., et al. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Neurology 70 13 Pt 2 (Mar 25 2008) 1084-1091
4. Hoogervorst E.L., Eikelenboom M.J., Uitdehaag B.M., and Polman C.H. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 74 4 (Apr 2003) 439-442
5. Mitchell A.J., Benito-Leon J., Gonzalez J.M., and Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 4 9 (Sep 2005) 556-566
6. Nortvedt M.W., and Riise T. The use of quality of life measures in multiple sclerosis research. Mult Scler 9 1 (Feb 2003) 63-72
7. Ozakbas S., Akdede B.B., Kosehasanogullari G., Aksan O., and Idiman E. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy. J Neurol Sci 256 1-2 (May 15 2007) 30-34
8. Rudick R.A., Miller D., Hass S., Hutchinson M., Calabresi P.A., Confavreux C., et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol 62 4 (Oct 2007) 335-346
9. Simone I.L., Ceccarelli A., Tortorella C., Bellacosa A., Pellegrini F., Plasmati I., et al. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes 4 (2006) 96
10. Gold S.M., Heesen C., Schulz H., Guder U., Monch A., Gbadamosi J., et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler 7 2 (Apr 2001) 119-130
11. Gold S.M., Schulz H., Monch A., Schulz K.H., and Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 9 4 (Aug 2003) 404-410
12. Revicki D., Hays R.D., Cella D., and Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61 2 (Feb 2008) 102-109
13. Revicki D.A., Cella D., Hays R.D., Sloan J.A., Lenderking W.R., and Aaronson N.K. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 4 (2006) 70
14. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
15. Mumford C.J., and Compston A. Problems with rating scales for multiple sclerosis: a novel approach-the CAMBS score. J Neurol 240 4 (1993) 209-215
16. Liang M.H., Lew R.A., Stucki G., Fortin P.R., and Daltroy L. Measuring clinically important changes with patient-oriented questionnaires. Med Care 40 4 Suppl (Apr 2002) II45-II51
17. Granger C.V., Cotter A.C., Hamilton B.B., Fiedler R.C., and Hens M.M. Functional assessment scales: a study of persons with multiple sclerosis. Arch Phys Med Rehabil 71 11 (1990 Oct) 870-875
18. Collen F.M., Wade D.T., Robb G.F., and Bradshaw C.M. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud 13 2 (Apr-Jun 1991) 50-54
19. Schulz K.H., Gold S.M., Witte J., Bartsch K., Lang U.E., Hellweg R., et al. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci 225 1-2 (Oct 15 2004) 11-18
20. Liang M.H., Larson M.G., Cullen K.E., and Schwartz J.A. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 28 5 (May 1985) 542-547
21. Norman G.R., Sloan J.A., and Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 5 (May 2003) 582-592
22. Hobart J.C., Riazi A., Lamping D.L., Fitzpatrick R., and Thompson A.J. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. J Neurol Neurosurg Psychiatry 76 11 (Nov 2005) 1539-1543
23. Khan F., Pallant J.F., Brand C., and Kilpatrick T.J. Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 79 11 (Nov 2008) 1230-1235
24. Freeman J.A., Hobart J.C., and Thompson A.J. Does adding MS-specific items to a generic measure (the SF-36) improve measurement?. Neurology 57 1 (Jul 10 2001) 68-74
25. Greenhalgh J., Ford H., Long A.F., and Hurst K. The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis. J Neurol Neurosurg Psychiatry 75 4 (Apr 2004) 577-582
26. Bethoux F., Miller D.M., and Kinkel R.P. Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life. Mult Scler 7 2 (Apr 2001) 137-142
27. Tripoliti E., Campbell C., Pring T., and Taylor-Goh S. Quality of life in multiple sclerosis: should clinicians trust proxy ratings?. Mult Scler 13 9 (Nov 2007) 1190-1194